For example, the release of endovanilloids by NPCs activates the transient receptor potential vanilloid subfamily member-1 (TRPV1) on glioblastoma cells, thereby reducing glioma expansion and prolonging survival time [148]. This evidence concerns the gene TRPV1 and glioma.